Q1 2026 · 13F-HR
Arrowpoint Investment Partners (Singapore) Pte. Ltd.holdings as filed
Filed 2026-05-14 · accession 0002032331-26-000010
$112.5M
Reported value
82
Positions
2026-03-31
Period end
The Brief · Arrowpoint Investment Partners (Singapore) Pte. Ltd. · Q1 2026
AI · grounded in 13F
Arrowpoint Investment Partners (Singapore) Pte. Ltd. closed its position in NVDA, reducing exposure by $82.45M. The fund also exited positions in MSFT for $70.12M and C for $54.14M. Offsetting these sales, the fund established a new position in IGV worth $18.48M and added SMH with a $8.43M investment.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 464287515 | IGV | ISHARES TR | $18.5M | 16.4% | 230,800 | CALL | NONE |
| 500767306 | KWEB | KRANESHARES TRUST | $11.4M | 10.1% | 400,000 | CALL | NONE |
| 02079K305 | GOOGL | ALPHABET INC | $9.0M | 7.96% | 31,127 | Common | SOLE |
| 92189F676 | SMH | VANECK ETF TRUST | $8.4M | 7.49% | 22,000 | PUT | NONE |
| 464286400 | EWZ | ISHARES INC | $4.6M | 4.09% | 120,000 | CALL | NONE |
| 00215W100 | ASX | ASE TECHNOLOGY HLDG CO LTD | $3.9M | 3.46% | 179,512 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $2.9M | 2.60% | 38,988 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $2.8M | 2.52% | 21,556 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC. | $2.8M | 2.46% | 16,401 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $2.8M | 2.45% | 48,719 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $2.7M | 2.40% | 11,828 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $2.7M | 2.40% | 39,701 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $2.0M | 1.78% | 71,313 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $1.9M | 1.72% | 2,502 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $1.9M | 1.72% | 7,902 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $1.7M | 1.54% | 4,934 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $1.7M | 1.48% | 11,961 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $1.5M | 1.35% | 3,412 | Common | SOLE |
| 595017BG8 | MCHP 0.75 06/01/30 | MICROCHIP TECHNOLOGY INC. | $1.5M | 1.32% | 1,500,000 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $1.4M | 1.25% | 5,216 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $1.2M | 1.10% | 3,855 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $1.1M | 1.02% | 7,018 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $983,804 | 0.87% | 9,334 | Common | SOLE |
| 07782B104 | BLTE | BELITE BIO INC | $957,278 | 0.85% | 6,004 | Common | SOLE |
| 46434G772 | EWT | ISHARES INC | $886,500 | 0.79% | 12,500 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $868,528 | 0.77% | 17,097 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $867,353 | 0.77% | 3,500 | PUT | NONE |
| 09062X103 | BIIB | BIOGEN INC | $862,751 | 0.77% | 4,706 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $777,247 | 0.69% | 25,805 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $775,180 | 0.69% | 7,971 | Common | SOLE |
| 81369Y886 | XLU | SELECT SECTOR SPDR TR | $752,596 | 0.67% | 16,400 | Common | SOLE |
| 023139884 | OSG | OCTAVE SPECIALTY GROUP INC | $647,131 | 0.58% | 139,168 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORP | $640,380 | 0.57% | 13,476 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $623,976 | 0.55% | 1,192 | Common | SOLE |
| 464287432 | TLT | ISHARES TR | $615,499 | 0.55% | 7,100 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $612,383 | 0.54% | 6,890 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $593,970 | 0.53% | 2,970 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $539,124 | 0.48% | 16,273 | Common | SOLE |
| 81369Y704 | XLI | SELECT SECTOR SPDR TR | $533,709 | 0.47% | 3,300 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $530,546 | 0.47% | 13,784 | Common | SOLE |
| 81369Y506 | XLE | SELECT SECTOR SPDR TR | $520,710 | 0.46% | 8,500 | Common | SOLE |
| 81369Y308 | XLP | SELECT SECTOR SPDR TR | $516,474 | 0.46% | 6,300 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $486,943 | 0.43% | 7,388 | Common | SOLE |
| 372303206 | GMAB | GENMAB A/S | $430,085 | 0.38% | 16,030 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $429,594 | 0.38% | 5,785 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $428,086 | 0.38% | 20,463 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $421,564 | 0.37% | 5,896 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $406,538 | 0.36% | 442 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $402,024 | 0.36% | 24,847 | Common | SOLE |
| 55024U109 | LITE | LUMENTUM HLDGS INC | $394,951 | 0.35% | 562 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $372,985 | 0.33% | 3,026 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $363,722 | 0.32% | 20,796 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $337,269 | 0.30% | 4,007 | Common | SOLE |
| 45256X103 | IBRX | IMMUNITYBIO INC | $314,508 | 0.28% | 41,005 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $312,500 | 0.28% | 527 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $312,072 | 0.28% | 17,213 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $309,702 | 0.28% | 6,140 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $309,273 | 0.27% | 8,075 | Common | SOLE |
| 81369Y605 | XLF | SELECT SECTOR SPDR TR | $306,094 | 0.27% | 6,200 | Common | SOLE |
| 78462F103 | SPY | STATE STR SPDR S&P 500 ETF T | $273,143 | 0.24% | 420 | Common | SOLE |
| 022307102 | ALMS | ALUMIS INC | $265,043 | 0.24% | 12,031 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $252,460 | 0.22% | 5,147 | Common | SOLE |
| 29452E101 | EQH | EQUITABLE HLDGS INC | $252,125 | 0.22% | 6,794 | Common | SOLE |
| 35473P686 | FLTW | FRANKLIN TEMPLETON ETF TR | $252,007 | 0.22% | 3,700 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $230,099 | 0.20% | 12,136 | Common | SOLE |
| 29415F104 | NVST | ENVISTA HOLDINGS CORPORATION | $228,355 | 0.20% | 9,001 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $228,082 | 0.20% | 3,370 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $227,838 | 0.20% | 3,628 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $203,619 | 0.18% | 2,830 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $201,958 | 0.18% | 4,190 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $191,701 | 0.17% | 36,170 | Common | SOLE |
| 92189F106 | GDX | VANECK ETF TRUST | $183,540 | 0.16% | 2,000 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $168,442 | 0.15% | 24,590 | Common | SOLE |
| 911549103 | UAMY | UNITED STATES ANTIMONY CORP | $99,749 | 0.09% | 11,426 | Common | SOLE |
| 02079K107 | GOOG | ALPHABET INC | $86,058 | 0.08% | 300 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $69,358 | 0.06% | 19,760 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $31,200 | 0.03% | 16,000 | Common | SOLE |
| 105368203 | BDN | BRANDYWINE RLTY TR | $28,997 | 0.03% | 10,700 | Common | SOLE |
| 81369Y803 | XLK | SELECT SECTOR SPDR TR | $26,580 | 0.02% | 200 | Common | SOLE |
| 72919P202 | PLUG | PLUG PWR INC | $25,330 | 0.02% | 11,208 | Common | SOLE |
| 46429B598 | INDA | ISHARES TR | $23,420 | 0.02% | 500 | Common | SOLE |
| 500767306 | KWEB | KRANESHARES TRUST | $11,372 | 0.01% | 400 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.